AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,712 | 126,404 | 121,816 | 126,105 | 137,559 |
| Receivables | 3,266 | 933 | 2,866 | 1,560 | 1,484 |
| Other current assets | 1,211 | 2,845 | 862 | 1,096 | 530 |
| TOTAL | $122,866 | $131,645 | $127,606 | $130,755 | $141,848 |
| Non-Current Assets | |||||
| PPE Net | 3,539 | 2,391 | 2,634 | 2,440 | 2,076 |
| Investments And Advances | 222 | 128 | 131 | 128 | 126 |
| TOTAL | $3,760 | $2,519 | $2,765 | $2,568 | $2,202 |
| Total Assets | $126,627 | $134,165 | $130,371 | $133,323 | $144,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,247 | 1,110 | 1,415 | 969 | 2,631 |
| Accrued Expenses | 7,760 | 8,442 | 7,093 | 4,739 | 4,869 |
| TOTAL | $9,051 | $9,913 | $8,549 | $6,054 | $7,628 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 43 | 361 | 42 | 346 | 128 |
| Other Non-Current Liabilities | 5,458 | 5,107 | 4,314 | 4,111 | 3,873 |
| TOTAL | $5,917 | $5,508 | $4,722 | $4,503 | $3,873 |
| Total Liabilities | $14,968 | $15,421 | $13,271 | $10,557 | $11,501 |
| Shareholders' Equity | |||||
| Common Shares | 1,210 | 1,166 | 1,188 | 1,160 | 1,135 |
| Retained earnings | -88,287 | -73,791 | -79,700 | -69,518 | -56,062 |
| TOTAL | $111,659 | $118,744 | $117,100 | $122,766 | $132,548 |
| Total Liabilities And Equity | $126,627 | $134,165 | $130,371 | $133,323 | $144,050 |